XML 34 R15.htm IDEA: XBRL DOCUMENT v3.22.2.2
Marketable Securities & Fair Value Measurements
12 Months Ended
Jun. 30, 2022
Fair Value Disclosures [Abstract]  
Marketable Securities & Fair Value Measurements
7. Marketable Securities & Fair Value Measurements

The Company’s marketable securities are classified on the consolidated balance sheet as follows:
June 30,June 30,
20222021
Short-term available-for-sale debt securities$88,375 $129,908 
Long-term available-for-sale debt securities4,810 5,748 
Available-for-sale debt securities93,185 135,656 
Mutual funds224 312 
Total marketable securities$93,409 $135,968 

Available-for-sale debt securities are invested in the following financial instruments:
As of June 30, 2022
Amortized CostUnrealized GainsUnrealized LossesFair Value
Commercial paper$36,800 $— $— $36,800 
U.S. government securities14,994 — (67)14,927 
Corporate debt27,193 — (142)27,051 
Asset backed securities14,465 — (58)14,407 
  Total available-for-sale debt securities$93,452 $— $(267)$93,185 

As of June 30, 2021
Amortized CostUnrealized GainsUnrealized LossesFair Value
Commercial paper$47,361 $— $— $47,361 
U.S. government securities20,229 — 20,230 
Corporate debt57,134 12 (12)57,134 
Asset backed securities10,922 10 (1)10,931 
Total available-for-sale debt securities$135,646 $23 $(13)$135,656 

The following table provides information by level for the Company’s marketable securities that were measured at fair value on a recurring basis:
Fair Value Measurements as of June 30, 2022
Using Inputs Considered as
Fair ValueLevel 1Level 2Level 3
Commercial paper$36,800 $— $36,800 $— 
U.S. government securities14,927 — 14,927 — 
Corporate debt27,051 — 27,051 — 
Asset backed securities14,407 — 14,407 — 
Mutual funds224 108 116 — 
  Total marketable securities$93,409 $108 $93,301 $— 
Fair Value Measurements as of June 30, 2021
Using Inputs Considered as
Fair ValueLevel 1Level 2Level 3
Commercial paper$47,361 $— $47,361 $— 
U.S. government securities20,230 — 20,230 — 
Corporate debt57,134 — 57,134 — 
Asset backed securities10,931 — 10,931 — 
Mutual funds312 136 176 — 
  Total marketable securities$135,968 $136 $135,832 $— 

The Company’s marketable securities classified within Level 1 are valued using real-time quotes for transactions in active exchange markets. Marketable securities within Level 2 are valued using readily available pricing sources. There were no transfers of assets between Level 1 and Level 2 of the fair value measurement hierarchy during the year ended June 30, 2022. Any transfers between levels would be recognized on the date of the event or when a change in circumstances causes a transfer.

Strategic Investments

The Company holds equity investments that do not have readily determined fair values. The Company has elected to measure these investments at cost minus impairment, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Impairment is reviewed each reporting period by performing a qualitative assessment considering impairment indicators to evaluate whether the investment is impaired.

As of June 30, 2022 and June 30, 2021, the carrying value of these investments was $12,333 and $11,706, respectively. During the year ended June 30, 2022, no impairment indicators were noted. The Company is committed to funding an additional $1,410 into one of these investments in the future. The Company holds options to acquire all outstanding equity or certain developed technologies with respect to some of these strategic investments. These investments are recorded within strategic investments on the consolidated balance sheet.

The Company also holds strategic investments accounted for as available-for-sale debt securities, which have carrying values and approximated fair values of $21,092 as of June 30, 2022. These investments are recorded within strategic investments on the consolidated balance sheet. The fair value of these investments are measured using Level 3 inputs and are not included in the tables above. Impairment is assessed similar to the Company's other strategic investments and no impairment indicators were noted during the year ended June 30, 2022.